Ledger.Open graph →
SEC Form D · Amendment · filed August 29, 2012

EIGER BIOPHARMACEUTICALS INC

Offering
$5.0M
Sold
$4.6M
Exemption
Industry
Biotechnology
Location
Santa Clara, CA
Type

People & firms on this filing (9)

Sridhar Bearelly · New York, NYExec · DirectorJacob Freifeld · Palo Alto, CADirectorDavid Deutsch · New York, NYDirectorTracy Overath · Austin, TXDirectorStuart Griffiths · Grand Cayman, Cayman IslandsExec · DirectorJason Vickers · Grand Cayman, Cayman IslandsDirectorJesper Poulsen · New York, NYDirectorPaul Truex · Santa Clara, CADirectorGlen Sato · Bothell, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗